Scott & Selber Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-58,706
| Closed | -$2.44M | – | 91 |
|
|
2024
Q2 | $2.44M | Sell |
58,706
-24,551
| -29% | -$1.02M | 0.78% | 39 |
|
|
2024
Q1 | $4.52M | Sell |
83,257
-1,463
| -2% | -$79.3K | 1.54% | 17 |
|
|
2023
Q4 | $4.35M | Sell |
84,720
-6,638
| -7% | -$341K | 1.63% | 15 |
|
|
2023
Q3 | $5.3M | Sell |
91,358
-872
| -0.9% | -$50.6K | 2.19% | 7 |
|
|
2023
Q2 | $5.9M | Sell |
92,230
-192
| -0.2% | -$12.3K | 2.31% | 7 |
|
|
2023
Q1 | $6.41M | Buy |
92,422
+101
| +0.1% | +$7K | 2.73% | 4 |
|
|
2022
Q4 | $6.64M | Sell |
92,321
-66
| -0.1% | -$4.75K | 2.99% | 3 |
|
|
2022
Q3 | $6.57M | Buy |
92,387
+384
| +0.4% | +$27.3K | 3.16% | 5 |
|
|
2022
Q2 | $7.08M | Sell |
92,003
-464
| -0.5% | -$35.7K | 3.23% | 4 |
|
|
2022
Q1 | $6.75M | Sell |
92,467
-3,020
| -3% | -$221K | 2.6% | 5 |
|
|
2021
Q4 | $5.95M | Buy |
95,487
+13,775
| +17% | +$859K | 2.11% | 7 |
|
|
2021
Q3 | $4.84M | Buy |
81,712
+46,636
| +133% | +$2.76M | 1.96% | 8 |
|
|
2021
Q2 | $2.34M | Buy |
35,076
+17,428
| +99% | +$1.16M | 0.9% | 29 |
|
|
2021
Q1 | $1.11M | Buy |
+17,648
| New | +$1.11M | 0.46% | 84 |
|
|
2020
Q4 | – | Sell |
-28,897
| Closed | -$1.74M | – | 101 |
|
|
2020
Q3 | $1.74M | Buy |
28,897
+331
| +1% | +$20K | 0.78% | 55 |
|
|
2020
Q2 | $1.68M | Sell |
28,566
-362
| -1% | -$21.3K | 0.83% | 52 |
|
|
2020
Q1 | $1.61M | Buy |
28,928
+197
| +0.7% | +$11K | 1.01% | 47 |
|
|
2019
Q4 | $1.84M | Buy |
+28,731
| New | +$1.84M | 0.87% | 53 |
|